miRNA–mRNA network analysis further indicated potential post-transcriptional regulatory mechanisms; collectively, these findings identified CYP4F3 as a negative prognostic biomarker and a potential therapeutic target in this type of cancer [79]. Here, CYP4F3 is linked to cancer.